Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.51 USD | +0.48% | -2.34% | -19.13% |
01/05 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
01/05 | Maxim Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.13% | 81.3B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences : Says Breast Cancer Therapy Receives Positive Opinion by European Medicines Agency